The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC).
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Kunwer Sufyan Faisal
No Relationships to Disclose
 
Ammad Raina
No Relationships to Disclose
 
Kaneez Zahra Rubab Khakwani
No Relationships to Disclose
 
Zaryab Bin Riaz
No Relationships to Disclose
 
Vishal S. Shah
No Relationships to Disclose
 
Ewan Kemar Cobran
No Relationships to Disclose
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; ImmunityBio; Janssen Oncology; Seagen (Inst); Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Syed A. Hussain
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bayer; Bayer; Castle Biosciences; Horizon CME; Janssen; Janssen Oncology; Lilly; Myovant Sciences; Myovant Sciences; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals; Verity Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Clovis Oncology (Inst); Pfizer; Pfizer (Inst); Phosplatin Therapeutics (Inst)
 
Irbaz Bin Riaz
No Relationships to Disclose